Orphan designation: valganciclovir,nanatinostat Treatment of diffuse large B-cell lymphoma, 13/01/2023 Withdrawn | European Federation of Internal Medicine

Submitted by Anonymous (not verified) on 4 September 2025 - 11:07

Orphan designation: valganciclovir,nanatinostat Treatment of diffuse large B-cell lymphoma, 13/01/2023 Withdrawn

Link:

https://www.ema.europa.eu/en/medicines/human/orphan-designations/eu-3-22-2742

Source:

Newsletters

Stay informed on our latest news!

Latest Newsletters